A study in mice funded by the National Institutes of Health (NIH) shows for the first time that high-contrast visual stimulation can help damaged retinal neurons regrow optic nerve fibers, otherwise known as retinal ganglion cell axons.
NEI research fellow Nathan Hotaling, PhD, has been awarded a $65,000 grant from the Knights Templar Eye Foundation to develop a stem cell-based system to study Best disease, a genetic disorder that can cause progressive vision loss.
Retinas from our earliest vertebrate ancestors had cone-like photoreceptors, presumably allowing them to see in daylight, but little ability to see at night.
News from NEI Grantees
- Pain medicine helps preserve vision in model of inherited retinal degeneration June 27, 2016
- Researchers Find Immunosuppressive Medication An Effective Treatment For Ocular Graft-Versus-Host-Disease April 13, 2016
- Scientists reveal new target for anti-lymphangiogenesis drugs April 12, 2016
- Largest Eye Study Among Chinese Americans Identifies More Effective Ways to Prevent and Treat Blinding Eye Diseases for This Racial Group April 8, 2016
- Neuronal Feedback Could Change What We “See” March 29, 2016
- Nerve injury appears to be root of diabetes-related vision loss March 23, 2016
- IUPUI researchers use stem cells to identify cellular processes related to glaucoma March 21, 2016
- Before retinal cells die, they regenerate, Penn Vet blindness study finds March 18, 2016